Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1241 of 5804
-
Could a cheaper copy of ocrevus work just as well for MS?
Disease control OngoingThe goal of this clinical trial is to learn if drug CYB704, a proposed biosimilar to Ocrevus, works to treat multiple sclerosis in the same way as the reference product Ocrevus(R). The main questions it aims to answer are: * Is CYB704 distributed in the body in the same way as …
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New PNH drug iptacopan tested in Real-World chinese study
Disease control Recruiting nowThe implementation of new standards for the management of PNH and the use of iptacopan in patients with PNH are expected to change the treatment landscape and improve the overall prognosis of patients. Based on these backgrounds, we plan to conduct a real-world study of iptacopa…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Lung cancer patients get a second shot: CyberKnife boost after chemoradiation
Disease control Recruiting nowThis is a monocentric, non-randomized, open-label, superiority phase II clinical investigation evaluating the efficacy of additional Cyberknife irradiation after a doublet of Platinum Salts-based chemotherapy and concomitant radiotherapy in patients with locally advanced non-smal…
Phase: PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Pig cell transplant trial aims to stop severe low blood sugar in type 1 diabetes
Disease control Recruiting nowThis study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and efficacy of OPF-310 transplantation and to define the recommended Phase 2 dose (RP2D) in adult subjects wit…
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Factory, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gum treatment may ease heart failure burden
Disease control OngoingHeart failure (HF) is a rapidly growing public health issue affecting more than 40 million individuals globally; while gum disease with bone loss affects 50% of people in general. The objective of this study is to evaluate the effect of dental treatment on blood levels of a HF pa…
Phase: NA • Sponsor: University of Taubate • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can telehealth help treat opioid addiction in rural and minority areas?
Disease control Recruiting nowOur primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment…
Phase: PHASE1 • Sponsor: Boulder Care • Aim: Disease control
Last updated Jun 26, 2026 15:32 UTC
-
Blood test may unmask Alzheimer's during hospital stays
Diagnosis Recruiting nowThe goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood …
Phase: NA • Sponsor: Covenant Health, US • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Streamlined liver cancer treatment tested in new study
Disease control Recruiting nowIn patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel, tumor size \< 5cm), radioembolization is performed without MAA scan with SIR-Spheres. This prospective registr…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a simple supplement boost muscle strength before lung transplant?
Disease control CompletedLung transplantation (LTx) is an accepted treatment option for patients with end-stage lung disease who do not respond to non-transplant treatments. Lung transplantation (LTx) is an accepted treatment option for patients with end-stage lung disease who do not respond to non-trans…
Phase: NA • Sponsor: Okan University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill could tame inherited high cholesterol in major trial
Disease control OngoingThis is a study to evaluate the efficacy and safety of AZD0780 in adults with HeFH and elevated LDL-C, either with clinical ASCVD and LDL-C levels of 55 mg/dL or higher or without clinical ASCVD and LDL-C levels of 70 mg/dL or higher. AZD0780 is a small molecule that reduces the …
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Microdose of LSD may lift depression mood, early trial hints
Symptom relief CompletedThis study will examine the effect of a low dose of the 5HT2A agonist LSD (26 µg), compared to placebo, on acute and protracted mood states in individuals with depression. The investigators will assess the relationship between mood-related symptoms and EEG as a neurophysiological…
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New drug aims to shrink cysts in genetic kidney disease
Disease control Recruiting nowAutosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that causes fluid-filled cysts to develop in the kidneys. The purpose of this study is to assess the safety and efficacy of ABBV-CLS-628 for the treatment of ADPKD in adult par…
Phase: PHASE2 • Sponsor: Calico Life Sciences LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New nasal spray could help those with stubborn depression
Disease control Recruiting nowThe purpose of this study is to evaluate how well esketamine nasal spray works in improving depressive symptoms in participants with treatment resistant depression (TRD). This will be assessed by the change from baseline in the Hamilton depression rating scale (HAM-D; 17-item) to…
Phase: PHASE4 • Sponsor: Janssen Korea, Ltd., Korea • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo aims to tame rare kidney disease
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Avacopan together with low-dose glucocorticoid in the treatment of patients with crescentic Imunoglobulin A Nephropathy (IgAN) and high risk of progression.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug shows promise for painful skin condition
Disease control OngoingThis is a phase 2b randomized, double-blind, placebo-controlled study of the safety and efficacy of tulisokibart in participants with moderate to severe hidradenitis suppurativa. The primary hypothesis is that at least 1 dose of tulisokibart is superior to placebo with respect to…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental drug brincidofovir targets Hard-to-Treat lymphomas
Disease control TerminatedThis study is a multi-center, global, open-label, Phase 1b/2 clinical study, and it will be conducted at multiple study sites in several countries, including Japan, Korea, and Singapore, to reveal the safety, tolerability, dose limiting toxicity (DLT), maximum tolerated dose (MTD…
Phase: PHASE1, PHASE2 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Brain zaps and poles: new combo therapy for Parkinson's gait
Symptom relief Recruiting nowParkinson's disease can cause slow or unsteady walking and balance problems that raise the risk of falls. This study will test whether adding a gentle, non-invasive brain stimulation called transcranial direct current stimulation (tDCS) during a supervised Nordic Walking program …
Phase: NA • Sponsor: Universidade Metodista de Piracicaba • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Focused radiation may spare prostate cancer patients from harsh side effects
Symptom relief Recruiting nowThis is a phase II non-blinded randomized controlled trial of image-guided, tumor-focused radiotherapy in patients with intermediate- or high-risk prostate cancer planning to undergo definitive radiotherapy with or without systemic therapy. The image-guided, tumor-focused radioth…
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New pill could ease endometriosis pain without needles
Symptom relief OngoingTo verify the non-inferiority of KLH-2109 to leuprorelin acetate in a double-blind manner in terms of efficacy in endometriosis patients with pelvic pain.
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New pill could calm agitation in Alzheimer's patients
Symptom relief Recruiting nowThis is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease.
Phase: PHASE2 • Sponsor: Celgene • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC